Analysis & Insights

Is the Australian Cannabis Index in the Midst of a Sector-Wide Upswing?

Many analysts believe this is the result of broader market forces, along with the cannabis referendums that took place during the 2020 election.Although the Australian cannabis ind...

The Potential Effect Of The U.S Election On Cannabis Businesses

Because the federal government still considers marijuana a controlled substance, U.S. cannabis businesses are forced to operate in cash, but they can't access banking services and,...

Intrinsic Value Assessment of Trulieve

Many companies have aimed at making a name for themselves in the cannabis market, but no company has reached a more dominant state-wide position than Trulieve. As we slowly gain tr...

Will Betting Big on Coronavirus Lead to a Rebound for the Australian Cannabis Index?

We're taking an in depth look at some of the ASX-listed shares that have driven the market forward over the last week. The Australian cannabis market has continued to expand at ara...

Cannabis Stocks Climb Amid Biden Presidency

Following the apparent victory of Joe Biden against Donald Trump for the U.S. Presidency, the cannabis stock market skyrocketed. It appears that cannabis investors are bullish on t...

Will New Jersey's Cannabis Referendum Reignite the Legalization Debate?

The Garden State is about to get a lot greener, and it could set off a wave of cannabis legalization across the Eastern Seaboard. New Jersey's upcoming cannabis referendum is causi...

Intrinsic Value Assessment of GW Pharmaceuticals

Should you invest in GW Pharmaceuticals' stock? Find out here in this assessment of GWPH's stock and intrinsic value.Since its inception, GW Pharmaceutical (NYSE:GWPH) has been lea...

Are Canopy Growth Stocks Still a Buy?

Few cannabis companies have risen to the heights that Canopy Growth has. But is the Canadian cannabis giant still all it's hyped up to be? In many ways, Canopy Growth (NYSE:CGC) se...

Are Marijuana Stocks On The Rise Again?

In 2019, the bubble well-and-truly burst for pot stocks, sending many investors running for the hills. Now, it looks like we're seeing the cannabis industry rally back up. As we've...

These Two ASX-Listed Cannabis Biotechs are Working on a COVID-19 Treatment

As the COVID-19 pandemic stretches on, many companies are vying to come up with a treatment - including two ASX-listed cannabis companies. Throughout the world, over 25 million cas...